DentalXChange, a leading provider of revenue cycle management for the dental industry, is proud to announce the expansion of their Executive Leadership Team with Alan Stein as Chief Solutions Officer. This strategic addition to the Executive Leadership Team reinforces DentalXChange’s commitment to growth, innovation, and excellence in service to its clients, partners, and stakeholders.
Health Technology Insights: INTENT Biologics Receives FDA Fast Track Designation for PEP Biologic
Alan brings more than 30 years of experience in healthcare technology to DentalXChange, with a strong emphasis on product management and development, marketing, strategy, commercialization, client success, and corporate development. As Chief Solutions Officer, he will work to advance DentalXChange’s product suite, with an eye to the adoption of new technologies against our industry’s leading solutions.
“I am thrilled to be joining DentalXChange as the CSO. The company is in a rare position where we build technology that allows payers, providers and partners to reduce cost and generate revenue while optimizing a patient experience,” said Alan Stein.
Health Technology Insights: Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit
“We are beyond excited to have Alan join our team. Alan’s deep payer subject matter expertise combined with his exceptional strength across strategy, product, commercialization, and corporate development will fuel exceptional value creation for all sides of our network. There is an industry need for much greater payer-provider collaboration which can positively impact all constituents and Alan’s experience will be a difference maker,” said Paul Kaiser, CEO at DentalXChange.
Previously, he had an extensive career as a senior executive at TriZetto, leading its $2.7 billion sale to Cognizant, where he then served as Senior Vice President overseeing the Healthcare Products Group. Recently, Alan served as Chief Solutions Officer for HealthEdge as a key executive in the multi-billion-dollar sale to Bain Capital.
Alan holds a bachelor’s degree from St. John’s University and an MBA in healthcare finance from CW Post University in Long Island.
Health Technology Insights: Novotech Appoints Anand Tharmaratnam as New CEO
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
Source- businesswire
